MOVE · Corvex, Inc. · Webcasts, Transcripts & Audio
$7.44
+0.37 (+5.16%)
At close · Oct 28
View the 10-Q filed May 19, 2026
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Customer concentration
— top customer 52% of revenue
One customer — 52% of revenue (the three months ended March 31, 2026)
“One customer accounted for approximately 52% of the Company’s revenue for the three months ended March 31, 2026, related to the Company’s AI cloud computing business.”
Market Cap
$195.47M
Shares
27.65M
Volume · Oct 28
35.54K
Avg daily vol (3M)
363.86K
Corvex, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Corvex, Inc. (MOVE), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q2
2026-08-14
Corvex, Inc. (MOVE) Q2 2026 Earnings Call Transcript
Positive tone
Revenue ramp and contracted annualized revenue
Security as differentiator
Corvex Token Factory product
Revenue
$3.80M
▲ 3590.3% YoY Diluted EPS
$-5.12
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-19
Corvex, Inc. (MOVE) Q1 2026 Earnings Call Transcript
Confident tone
AI Inference / Token Factory
Confidential Computing
AI Infrastructure / AI Factory Platform
Revenue
$510,000
▲ 147.6% YoY Diluted EPS
$-3.13
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-11-14
Corvex, Inc. (MOVE) Q3 2024 Earnings Call Transcript
Confident tone
FDA 510(k) clearance for EvieMED Ring
Smart ring market opportunity
Blood pressure and glucose technology (RF)
Revenue
$50,000
Diluted EPS
$-7.78
Gross margin
-1590.0%
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Corvex, Inc. (MOVE) Q2 2024 Earnings Call Transcript
Positive tone
FDA 510(k) Clearance for EV Med Ring
B2B Commercial Opportunities and Partnerships
Evie Ring Direct-to-Consumer Relaunch
Revenue
$23,000
Diluted EPS
$-6.85
Gross margin
-1552.2%
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-15
Corvex, Inc. (MOVE) Q1 2024 Earnings Call Transcript
Positive tone
FDA 510(k) clearance for Evie Med pulse oximeter
mmWave RF blood pressure and glucose technology
Evie Ring relaunch and customer experience improvements
Revenue
$852,000
Diluted EPS
$-11.27
Gross margin
-42.6%
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-04-04
Corvex, Inc. (MOVE) Q4 2023 Earnings Call Transcript
Confident tone
B2B opportunities for Evie Med
Blood pressure monitoring
FDA 510(k) clearance for SpO2/pulse rate
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-15
Corvex, Inc. (MOVE) Q3 2023 Earnings Call Transcript
Diluted EPS
$-19.51
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Corvex, Inc. (MOVE) Q2 2023 Earnings Call Transcript
Diluted EPS
$-18.78
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Corvex, Inc. (MOVE) Q1 2023 Earnings Call Transcript
Diluted EPS
$-20.99
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-20
Corvex, Inc. (MOVE) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Corvex, Inc. (MOVE) Q3 2022 Earnings Call Transcript
Diluted EPS
$-28.72
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-15
Corvex, Inc. (MOVE) Q2 2022 Earnings Call Transcript
Diluted EPS
$-23.20
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Corvex, Inc. (MOVE) Q1 2022 Earnings Call Transcript
Diluted EPS
$-23.20
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-30
Corvex, Inc. (MOVE) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Corvex, Inc. (MOVE) Q3 2021 Earnings Call Transcript
Diluted EPS
$-17.67
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Corvex, Inc. (MOVE) Q2 2021 Earnings Call
Diluted EPS
$-16.57
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Corvex, Inc. (MOVE) Q1 2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–17 of 17 webcasts